Significance of under- or over-representations of frequently mutated pathways across the 8 ROSE subgroups12
ROSE12 group . | TP53/RB1 signaling . | B-cell development . | Ras signaling . | JAK signaling . | ||||
---|---|---|---|---|---|---|---|---|
P . | OR . | P . | OR . | P . | OR . | P . | OR . | |
R1 | .056 | 0.21 | 3.78 × 10−5* | 0.108 | .041 | 0.26 | .23 | 0 |
R2 | .26 | 0.55 | .47 | 1.7 | .0001* | 0.056 | .14 | 0 |
R3 | .001* | ∞ | .18 | 0.371 | .53 | 0.52 | .62 | 0 |
R4 | .0035 | 11.4 | .065 | 6.12 | .39 | 1.73 | .37 | 0 |
R5 | .013 | 0.098 | .032 | 0.22 | .49 | 1.83 | .60 | 0 |
R6 | .019 | 0.301 | .32 | 0.593 | .058 | 2.58 | .14 | 0 |
R7 | .070 | 1.78 | .20 | 1.61 | 1.65 × 10−5 | 3.86 | 1 | 1.03 |
R8 | .51 | 1.374 | .0015* | 12.3 | .0005* | 0.114 | 4.15 × 10−9 | 2.44 |
ROSE12 group . | TP53/RB1 signaling . | B-cell development . | Ras signaling . | JAK signaling . | ||||
---|---|---|---|---|---|---|---|---|
P . | OR . | P . | OR . | P . | OR . | P . | OR . | |
R1 | .056 | 0.21 | 3.78 × 10−5* | 0.108 | .041 | 0.26 | .23 | 0 |
R2 | .26 | 0.55 | .47 | 1.7 | .0001* | 0.056 | .14 | 0 |
R3 | .001* | ∞ | .18 | 0.371 | .53 | 0.52 | .62 | 0 |
R4 | .0035 | 11.4 | .065 | 6.12 | .39 | 1.73 | .37 | 0 |
R5 | .013 | 0.098 | .032 | 0.22 | .49 | 1.83 | .60 | 0 |
R6 | .019 | 0.301 | .32 | 0.593 | .058 | 2.58 | .14 | 0 |
R7 | .070 | 1.78 | .20 | 1.61 | 1.65 × 10−5 | 3.86 | 1 | 1.03 |
R8 | .51 | 1.374 | .0015* | 12.3 | .0005* | 0.114 | 4.15 × 10−9 | 2.44 |
The P value was calculated using a 2-sided Fisher exact test.
OR indicates odds ratio.
P < .05 (significant) after correction for multiple testing using a Family-wise Error Rate.